You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 7月5日港股收盤
uSMART盈立智投 07-05 16:46

根據uSMART輿情監測數據,5日港股交易時段,市場關注指數最高的2只股票是藥明生物、商湯-W。

7月5日—港股關注排行TOP2

輿情變化榜單

藥明生物

個股K線圖

關注度第一爲藥明生物,該股今日收盤上漲6.51%,報於82.60港元。近5個交易日累計上漲7.76%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

恆生指數收漲0.10%報21853點 CRO概念股全線走高 藥明生物漲6.51%

港股午評:恆指漲超0.5% CRO板塊大漲 藥明生物漲8%

商湯-W

個股K線圖

關注度第二爲商湯-W,該股今日收盤上漲8.27%,報於2.75港元。近5個交易日累計下跌55.07%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

恆指升125點 藥明系彈高 商湯反覆揚近8%

商湯-W拉昇7% 機構指解禁擾動不改商業化長期變現潛力

此外,監測期內有1只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。

7月5日—港股輿情轉折預警

輿情變化榜單

商湯-W

個股K線圖

商湯-W輿情扭轉指數達100,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

恆指升125點 藥明系彈高 商湯反覆揚近8%

商湯-W拉昇7% 機構指解禁擾動不改商業化長期變現潛力

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account